Latest filing published 06 Oct 2026 for Sinopharm Tech Holdings Ltd., €7,645.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by HEUNG Pik Lun on record concern Sinopharm Tech Holdings Ltd., in the capacity of chief executive. Over a trading history stretching from 4 November 2025 to 5 October 2026, the count stands at 33 filings.
Market trades split into 32 purchases (€131k) and 1 sale (€7,645). On balance, insiders were net buyers of €123k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 11 purchases and 1 sale.
In size, the median ticket on the buying side is €3,328. As a share of market capitalisation, the median purchase stands at 0.011%, based on 4 purchases. No cluster: in 32 purchases, no other insider of the company bought within 30 days. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -36.1%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 6 October 2026: an open-market sale of €7,645, in Sinopharm Tech Holdings Ltd. The most recent open-market purchase was published on 5 May 2026, 172 days ago. The median gap between a trade and its publication by HKEX is 3 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations